TED Investigators Receive FDA Letter of Support for Neuroimaging Biomarkers

The TED Initiative has reached an important milestone in securing an FDA Letter of Support to further explore neuroimaging prognostic biomarkers that may be used to enrich TBI clinical trials with patients who display particular pathoanatomic features that have been associated with poor short to medium-term outcome following mild TBI. This letter, signed by Dr. Janet Woodcock, Director, FDA Center for Drug Evaluation and Research, represents a significant step forward for the field and an important accomplishment for the TED Initiative. 

Download Letter of Support